Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Revenue ContractionContracting
Percentile Rank44
5Y CAGR-50.6%
Year-over-Year Change

Total revenue from sales of goods and services

5Y CAGR
-50.6%/yr
Long-term compound
Percentile
P44
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
2024$582000.00+755.9%
2023$68000.00-
2022$0.00-
2021$0.00-
2020$0.00-100.0%
2019$19.81M-15.1%
2018$23.34M+9.7%
2017$21.27M-4.7%
2016$22.31M-9.0%
2015$24.52M-